Encompass Health Corp (EHC)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Days Sales Outstanding (DSO) is a financial ratio that measures the average number of days it takes for a company to collect revenue after a sale is made. In the case of Encompass Health Corp, the DSO data provided indicates that specific DSO values are not available for the periods from March 31, 2020, to December 31, 2024.
This lack of specific DSO values means that we currently do not have the necessary information to analyze Encompass Health Corp's efficiency in collecting accounts receivable and managing its cash flow from sales. Typically, a lower DSO value is preferred as it indicates faster collection of receivables and better liquidity. Conversely, a higher DSO may suggest potential issues with accounts receivable management and liquidity.
Given the absence of DSO data in the provided information, it is essential for stakeholders and investors interested in Encompass Health Corp to look for updated financial reports or sources to assess the company's collection efficiency over time. Monitoring DSO trends can provide valuable insights into the company's financial health and operational effectiveness.
Peer comparison
Dec 31, 2024